HIV-1 Evolution and Functional Correlates of MTCT

HIV-1 进化和 MTCT 功能相关性

基本信息

项目摘要

DESCRIPTION (provided by applicant): Mucosal transmission of HIV involves a strong bottleneck effect and most often, a single founder virus is transmitted. The relative contributions of stochastic (random) selection vs. active selection by specific viral and host characteristics to this bottleneck are unclear. Mother-to-child HIV-1 transmission (MTCT) through breastfeeding, in which transmission pairs and timing of infant infection are readily identified, provides an instructive model to address these important and unresolved questions. We will use serial samples from a large, well characterized cohort of HIV-1 infected Zimbabwean women who transmitted HIV-1 through breastmilk. This cohort includes women with chronic HIV-1 infection (CI; N=35), and women who acquired primary HIV-1 infection post-partum (acute infection, AI; N=13). We combine phylogenetics (with frequency analyses based on deep sequencing data) with functional assays (CD4 and co-receptor use, entry kinetics, neutralization sensitivity), to quantitatively and comprehensively analyze the relationship of founder viruses to maternal blood or breastmilk variants, quantify the relative contributions of stochastic vs. active selectio, identify selection pressures on envelope (env), differentiate when selection pressures may operate during the transmission bottleneck, and determine whether founder env variants are better adapted than other non- transmitted variants for postnatal MTCT. Delineation of the biologic properties of transmitted variants along with mapping the genetic bases of these biologic properties, should improve understanding of HIV-1 entry and the mechanisms of action of HIV-1 entry inhibitors. These studies will also improve our understanding of the in vivo selective pressures exerted by autologous neutralizing antibodies and innate factors in two distinct and relevant anatomic compartments (blood, where levels of antibodies are high, and breastmilk, where they are much lower) and the potential role of neutralization sensitivity or escape in transmission. Finally, these studies will specifically reveal whether increasing the neutralizing activity of blood or breastmilk (e.g., through passive or active immunization) or targeting other Env functional properties (tropism, infectivity) hold promise to block primary infection of women and children.
描述(由申请人提供):HIV的粘液传播涉及强烈的瓶颈效应,最常见的是传播单一的创始病毒。的相对贡献 随机(随机)选择与通过特定病毒和宿主特征进行的主动选择, 这个瓶颈还不清楚。通过母乳喂养进行的艾滋病毒1型母婴传播很容易确定传播对和婴儿感染的时间,这为解决这些重要和尚未解决的问题提供了一个有指导意义的模式。我们将使用来自一个大的,充分表征的HIV-1感染的津巴布韦妇女谁通过母乳传播HIV-1队列的系列样本。该队列包括患有慢性HIV-1感染的妇女(CI; N=35)和产后获得原发性HIV-1感染的妇女(急性感染,AI; N=13)。我们将联合收割机(基于深度测序数据的频率分析)(CD 4和共受体使用、进入动力学、中和敏感性),以定量和全面地分析创始病毒与母体血液或母乳变体的关系,量化随机选择与主动选择的相对贡献,鉴定对包膜(env)的选择压力,区分选择压力在传播瓶颈期间何时起作用,并确定创始者env变体是否比其他非传播变体更适合于出生后MTCT。描述传播变异体的生物学特性沿着绘制这些生物学特性的遗传基础,将提高对HIV-1进入和HIV-1进入抑制剂作用机制的理解。这些研究还将提高我们对自体中和抗体和先天因子在两个不同且相关的解剖隔室(血液,抗体水平高,母乳,抗体水平低得多)中施加的体内选择性压力以及中和敏感性或逃逸在传播中的潜在作用的理解。最后,这些研究将具体揭示增加血液或母乳的中和活性(例如,通过被动或主动免疫接种)或靶向其他Env功能特性(嗜性、传染性)有望阻断妇女和儿童的原发性感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Edward N Janoff其他文献

Edward N Janoff的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Edward N Janoff', 18)}}的其他基金

Complementary Mechanisms of Protection Against Pneumococcal Infection
预防肺炎球菌感染的补充机制
  • 批准号:
    10265361
  • 财政年份:
    2019
  • 资助金额:
    $ 79.03万
  • 项目类别:
Complementary Mechanisms of Protection Against Pneumococcal Infection
预防肺炎球菌感染的补充机制
  • 批准号:
    10454869
  • 财政年份:
    2019
  • 资助金额:
    $ 79.03万
  • 项目类别:
ShEEP Request for Assuring Research Reproducibility with an Integrated Sample and Data Management System
ShEEP 要求通过集成样本和数据管理系统确保研究的可重复性
  • 批准号:
    9796662
  • 财政年份:
    2019
  • 资助金额:
    $ 79.03万
  • 项目类别:
Complementary Mechanisms of Protection Against Pneumococcal Infection
预防肺炎球菌感染的补充机制
  • 批准号:
    9913982
  • 财政年份:
    2019
  • 资助金额:
    $ 79.03万
  • 项目类别:
Impact of HIV-1 and Aging on Mucosal Vaccine Responses
HIV-1 和衰老对粘膜疫苗反应的影响
  • 批准号:
    9856943
  • 财政年份:
    2017
  • 资助金额:
    $ 79.03万
  • 项目类别:
Impact of HIV-1 and Aging on Mucosal Vaccine Responses
HIV-1 和衰老对粘膜疫苗反应的影响
  • 批准号:
    9242519
  • 财政年份:
    2017
  • 资助金额:
    $ 79.03万
  • 项目类别:
Mechanisms of Impaired HIV-associated B cell and Pneumococcal Vaccine responses
HIV 相关 B 细胞和肺炎球菌疫苗反应受损的机制
  • 批准号:
    8659163
  • 财政年份:
    2013
  • 资助金额:
    $ 79.03万
  • 项目类别:
HIV-1 Evolution and Functional Correlates of MTCT
HIV-1 进化和 MTCT 功能相关性
  • 批准号:
    8787985
  • 财政年份:
    2012
  • 资助金额:
    $ 79.03万
  • 项目类别:
HIV-1 Evolution and Functional Correlates of MTCT
HIV-1 进化和 MTCT 功能相关性
  • 批准号:
    8423676
  • 财政年份:
    2012
  • 资助金额:
    $ 79.03万
  • 项目类别:
HIV-1 Evolution and Functional Correlates of MTCT
HIV-1 进化和 MTCT 功能相关性
  • 批准号:
    8329143
  • 财政年份:
    2012
  • 资助金额:
    $ 79.03万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.03万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 79.03万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.03万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.03万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 79.03万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.03万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.03万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.03万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 79.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 79.03万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了